Double blind, randomized controlled trial, to evaluate the effectiveness of a controlled nitric oxide releasing patch versus meglumine antimoniate in the treatment of cutaneous leishmaniasis

ABSTRACT: Background: Cutaneous Leishmaniasis is a worldwide disease, endemic in 88 countries, that has shown an increasing incidence over the last two decades. So far, pentavalent antimony compounds have been considered the treatment of choice, with a percentage of cure of about 85%. However, the h...

Full description

Autores:

Vélez Bernal, Iván Darío
Y Silva, Sandra
Rueda Guzmán, Ligia Clemencia
López, Marcos
Rueda Clausen, Christian
Smith, Daniel J.
Muñoz, Gerardo
Mosquera, Hernando
Silva Sieger, Federico Arturo
Buitrago López, Adriana
Díaz Hernández, Holger Horacio
López Jaramillo, Patricio

Tipo de recurso:

Article of investigation

Fecha de publicación:

2006

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/31172

Acceso en línea:

https://hdl.handle.net/10495/31172

Palabra clave:

Leishmaniasis Cutánea
Leishmaniasis, Cutaneous
Óxido Nítrico
Nitric Oxide
Antimoniato de Meglumina
Meglumine Antimoniate

Rights

openAccess

License

http://creativecommons.org/licenses/by/2.5/co/